Your browser doesn't support javascript.
loading
TET2 Regulates the Neuroinflammatory Response in Microglia.
Carrillo-Jimenez, Alejandro; Deniz, Özgen; Niklison-Chirou, Maria Victoria; Ruiz, Rocio; Bezerra-Salomão, Karina; Stratoulias, Vassilis; Amouroux, Rachel; Yip, Ping Kei; Vilalta, Anna; Cheray, Mathilde; Scott-Egerton, Alexander Michael; Rivas, Eloy; Tayara, Khadija; García-Domínguez, Irene; Garcia-Revilla, Juan; Fernandez-Martin, Juan Carlos; Espinosa-Oliva, Ana Maria; Shen, Xianli; St George-Hyslop, Peter; Brown, Guy Charles; Hajkova, Petra; Joseph, Bertrand; Venero, Jose Luis; Branco, Miguel Ramos; Burguillos, Miguel Angel.
Afiliación
  • Carrillo-Jimenez A; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Deniz Ö; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.
  • Niklison-Chirou MV; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.
  • Ruiz R; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Bezerra-Salomão K; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.
  • Stratoulias V; Institute of Environmental Medicine, Toxicology Unit, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Amouroux R; MRC London Institute of Medical Sciences/Institute of Clinical Sciences Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
  • Yip PK; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.
  • Vilalta A; Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK.
  • Cheray M; Institute of Environmental Medicine, Toxicology Unit, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Scott-Egerton AM; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK.
  • Rivas E; Department of Pathology, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.
  • Tayara K; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • García-Domínguez I; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Garcia-Revilla J; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Fernandez-Martin JC; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Espinosa-Oliva AM; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Shen X; Institute of Environmental Medicine, Toxicology Unit, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • St George-Hyslop P; Department of Clinical Neurosciences, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0SP, UK.
  • Brown GC; Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK.
  • Hajkova P; MRC London Institute of Medical Sciences/Institute of Clinical Sciences Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.
  • Joseph B; Institute of Environmental Medicine, Toxicology Unit, Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Venero JL; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain.
  • Branco MR; Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, London E1 2AT, UK. Electronic address: m.branco@qmul.ac.uk.
  • Burguillos MA; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Sevilla, Spain; Blizard Institute, Barts and The London School o
Cell Rep ; 29(3): 697-713.e8, 2019 10 15.
Article en En | MEDLINE | ID: mdl-31618637
Epigenomic mechanisms regulate distinct aspects of the inflammatory response in immune cells. Despite the central role for microglia in neuroinflammation and neurodegeneration, little is known about their epigenomic regulation of the inflammatory response. Here, we show that Ten-eleven translocation 2 (TET2) methylcytosine dioxygenase expression is increased in microglia upon stimulation with various inflammogens through a NF-κB-dependent pathway. We found that TET2 regulates early gene transcriptional changes, leading to early metabolic alterations, as well as a later inflammatory response independently of its enzymatic activity. We further show that TET2 regulates the proinflammatory response in microglia of mice intraperitoneally injected with LPS. We observed that microglia associated with amyloid ß plaques expressed TET2 in brain tissue from individuals with Alzheimer's disease (AD) and in 5xFAD mice. Collectively, our findings show that TET2 plays an important role in the microglial inflammatory response and suggest TET2 as a potential target to combat neurodegenerative brain disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Microglía / Proteínas de Unión al ADN Límite: Animals / Humans / Male Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Microglía / Proteínas de Unión al ADN Límite: Animals / Humans / Male Idioma: En Revista: Cell Rep Año: 2019 Tipo del documento: Article País de afiliación: España